HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annemarie Hasselberg Selected Research

CTA1R7K-COL-DD

6/2009Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annemarie Hasselberg Research Topics

Disease

2Inflammation (Inflammations)
01/2019 - 06/2009
1Asthma (Bronchial Asthma)
01/2019
1Experimental Arthritis
06/2009

Drug/Important Bio-Agent (IBA)

1AllergensIBA
01/2019
1Interleukin-5 (Interleukin 5)IBA
01/2019
1Interleukin-13IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
06/2009
1CytokinesIBA
06/2009
1CTA1R7K-COL-DDIBA
06/2009
1Collagen Type II (Type II Collagen)IBA
06/2009
1AntigensIBA
06/2009
1Cholera ToxinIBA
06/2009
1Peptides (Polypeptides)IBA
06/2009